Emergent BioSolutions Inc... (EBS)
Emergent BioSolutions Max Pain By Strike
EBS trades at $9.18, 31.1% above the near-term max pain of $7 expiring Sep 19, 2025 (30 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($5-$8), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Emergent BioSolutions Max Pain By Expiry
Max pain for EBS shows an upward trend from 5 to 8, suggesting bullish positioning in longer-dated options. The 49% spread signals divergent expectations across timeframes. Most levels below 9.18 may cap rallies. Strong magnetic level at 5 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 7 | -2.18 (-23.75%) |
| Oct 17, 2025 | 8 | -1.18 (-12.85%) |
| Dec 19, 2025 | 5 | -4.18 (-45.53%) |
| Jan 16, 2026 | 5 | -4.18 (-45.53%) |
| Mar 20, 2026 | 7 | -2.18 (-23.75%) |
| Jan 15, 2027 | 5 | -4.18 (-45.53%) |